Terms: = Lung cancer AND CCND1, BCL1, 595, ENSG00000110092, PRAD1, U21B31, D11S287E AND Treatment
115 results:
1. Association of ccnd1 rs9344 polymorphism with lung cancer susceptibility and clinical outcomes: a case-control study.
Mei C; Wang T; Xu B; Wu S; Zhang X; Lv Y; Zhang Y; Liu Z; Gong W
BMC Pulm Med; 2024 Apr; 24(1):167. PubMed ID: 38589850
[TBL] [Abstract] [Full Text] [Related]
2. Utility of molecular markers in predicting local control specific to lung cancer spine metastases treated with stereotactic body radiotherapy.
Shor D; Louie AV; Zeng KL; Menjak IB; Atenafu EG; Chia-Lin Tseng ; Detsky J; Larouche J; Zhang B; Soliman H; Myrehaug S; Maralani P; Hwang DM; Sahgal A; Chen H
J Neurooncol; 2024 Apr; 167(2):275-283. PubMed ID: 38526757
[TBL] [Abstract] [Full Text] [Related]
3. Real-World comprehensive genomic profiling data for diagnostic clarity in pulmonary Large-Cell neuroendocrine carcinoma.
Burns L; Tukachinsky H; Raskina K; Huang RSP; Schrock AB; Sands J; Kulke MH; Oxnard GR; Tapan U
Lung Cancer; 2024 Feb; 188():107454. PubMed ID: 38159439
[TBL] [Abstract] [Full Text] [Related]
4. Long-Term Intracranial Outcomes With Combination Dual Immune-Checkpoint Blockade and Stereotactic Radiosurgery in Patients With Melanoma and Non-Small Cell lung cancer Brain Metastases.
Vaios EJ; Shenker RF; Hendrickson PG; Wan Z; Niedzwiecki D; Winter SF; Shih HA; Dietrich J; Wang C; Salama AKS; Clarke JM; Allen K; Sperduto P; Mullikin T; Kirkpatrick JP; Floyd SR; Reitman ZJ
Int J Radiat Oncol Biol Phys; 2024 Apr; 118(5):1507-1518. PubMed ID: 38097090
[TBL] [Abstract] [Full Text] [Related]
5. [Study of genetic variants in 169 non-small cell lung cancer patients].
Formanti Alonso L; Atienza Cuevas L; Romero García R; Mohigefer Barrera J; Del Río Ignacio JJ; Santisteban Espejo A; Bernal Florindo I; Catalina Fernández I; García Rojo M
Rev Esp Patol; 2023; 56(4):233-242. PubMed ID: 37879820
[TBL] [Abstract] [Full Text] [Related]
6. Intrinsic Resistance to Osimertinib in EGFR Mutated NSCLC Cell Lines Induced by Alteration in Cell-Cycle Regulators.
Volta F; La Monica S; Leonetti A; Gnetti L; Bonelli M; Cavazzoni A; Fumarola C; Galetti M; Eltayeb K; Minari R; Petronini PG; Tiseo M; Alfieri R
Target Oncol; 2023 Nov; 18(6):953-964. PubMed ID: 37855989
[TBL] [Abstract] [Full Text] [Related]
7. Modified Bushen Yiqi formula enhances antitumor immunity by reducing the chemotactic recruitment of M2-TAMs and PMN-MDSCs in Lewis lung cancer-bearing mice.
Kong Q; Zhu H; Gong W; Deng X; Liu B; Dong J
J Ethnopharmacol; 2024 Jan; 319(Pt 1):117183. PubMed ID: 37739106
[TBL] [Abstract] [Full Text] [Related]
8. Oral uracil-tegafur compared with intravenous chemotherapy as adjuvant therapy for resected early-stage non-small cell lung cancer patients.
Liang SK; Wu CW; Chang CI; Keng LT; Lee MR; Wang JY; Ko JC; Liao WY; Chen KY; Ho CC; Shih JY; Yu CJ
Cancer Med; 2023 Sep; 12(17):17993-18004. PubMed ID: 37559409
[TBL] [Abstract] [Full Text] [Related]
9. FSIP1 enhances the therapeutic sensitivity to CDK4/6 inhibitors in triple-negative breast cancer patients by activating the Nanog pathway.
Chen G; Sun L; Gu X; Ai L; Yang J; Zhang Z; Hou P; Wang Y; Ou X; Jiang X; Qiao X; Ma Q; Niu N; Xue J; Zhang H; Yang Y; Liu C
Sci China Life Sci; 2023 Dec; 66(12):2805-2817. PubMed ID: 37460715
[TBL] [Abstract] [Full Text] [Related]
10. CSNK2A2 promotes hepatocellular carcinoma progression through activation of NF-κB pathway.
Yang S; Peng LR; Yu AQ; Li J
Ann Hepatol; 2023; 28(5):101118. PubMed ID: 37268061
[TBL] [Abstract] [Full Text] [Related]
11. Network pharmacology integrated with experimental validation revealed potential molecular mechanisms of Camellia nitidissima C. W. Chi in the treatment of lung cancer.
Zhou A; Zhou C; Wang D; Qian M; Huang L
J Ethnopharmacol; 2023 Oct; 314():116576. PubMed ID: 37142145
[TBL] [Abstract] [Full Text] [Related]
12. TP53 mutations predict poor response to immunotherapy in patients with metastatic solid tumors.
Kim JY; Jung J; Kim KM; Lee J; Im YH
Cancer Med; 2023 Jun; 12(11):12438-12451. PubMed ID: 37081749
[TBL] [Abstract] [Full Text] [Related]
13. Intrathecal chemotherapy combined with systemic therapy in patients with refractory leptomeningeal metastasis of non-small cell lung cancer: a retrospective study.
Zhou T; Zhu S; Xiong Q; Gan J; Wei J; Cai J; Liu A
BMC Cancer; 2023 Apr; 23(1):333. PubMed ID: 37041504
[TBL] [Abstract] [Full Text] [Related]
14. MARVELD3 inhibits the epithelial-mesenchymal transition and cell migration by suppressing the Wnt/β-catenin signaling pathway in non-small cell lung cancer cells.
Li S; Qi S; Li Y; Zhang C; Sun L; Liu C; Wang H
Thorac Cancer; 2023 Apr; 14(12):1045-1058. PubMed ID: 36924014
[TBL] [Abstract] [Full Text] [Related]
15. Individualized estimates of intensity-modulated radiotherapy plans after breast conservation surgery for left-sided breast cancer.
Wang Y; Ni L; Ying S; Xu Y; Chen W; Liu Y
World J Surg Oncol; 2023 Feb; 21(1):59. PubMed ID: 36823541
[TBL] [Abstract] [Full Text] [Related]
16. ERCC6 plays a promoting role in the progression of non-small cell lung cancer.
Luo H; Xiao Z; Huang C; Wu W; Xie Q
Biochem Cell Biol; 2023 Jun; 101(3):246-258. PubMed ID: 36802454
[TBL] [Abstract] [Full Text] [Related]
17. Inhibition of ribosome assembly factor PNO1 by CRISPR/Cas9 technique suppresses lung adenocarcinoma and Notch pathway: Clinical application.
Roy SK; Srivastava S; Hancock A; Shrivastava A; Morvant J; Shankar S; Srivastava RK
J Cell Mol Med; 2023 Feb; 27(3):365-378. PubMed ID: 36625087
[TBL] [Abstract] [Full Text] [Related]
18. Stratifying non-small cell lung cancer patients using an inverse of the treatment decision rules: validation using electronic health records with application to an administrative database.
Kim MH; Park S; Park YR; Ji W; Kim SG; Choo M; Hwang SS; Lee JC; Kim HR; Choi CM
BMC Med Inform Decis Mak; 2023 Jan; 23(1):3. PubMed ID: 36609301
[TBL] [Abstract] [Full Text] [Related]
19. Explore the mechanism and substance basis of Mahuang FuziXixin Decoction for the treatment of lung cancer based on network pharmacology and molecular docking.
Zhang W; Tian W; Wang Y; Jin X; Guo H; Wang Y; Tang Y; Yao X
Comput Biol Med; 2022 Dec; 151(Pt A):106293. PubMed ID: 36399857
[TBL] [Abstract] [Full Text] [Related]
20. Real-time image-guided treatment of mobile tumors in proton therapy by a library of treatment plans: a simulation study.
Hamaide V; Souris K; Dasnoy D; Glineur F; Macq B
Med Phys; 2023 Jan; 50(1):465-479. PubMed ID: 36345808
[TBL] [Abstract] [Full Text] [Related]
[Next]
